| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Director, 10% Owner
2 companies
Evnin Luke is a Director, 10% Owner at SNDX, with reported holdings spanning 2 companies. Recent filings cover 1 purchase and 88 sales.
Our model assigns Evnin Luke a middling insider score of 56/100, based on 62 past trades. Over a 12-month horizon, 50.0% of those trades were profitable, with an average 12-month return of -19.9%.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 12, 2025 | HOWL Werewolf Therapeutics, Inc. | Director | Sell | 82,971 | $1.07 | $88,586.51 | -2.8% | -24.9% | - | |
| Dec 9, 2025 | HOWL Werewolf Therapeutics, Inc. | Director | Sell | 95,179 | $1.00 | $94,787.25 | -3.1% | -27.5% | - | |
| Dec 4, 2025 | HOWL Werewolf Therapeutics, Inc. | Director | Sell | 128,185 | $0.92 | $117,623.41 | -4.0% | -38.8% | - | |
| Dec 1, 2025 | HOWL Werewolf Therapeutics, Inc. | Director | Sell | 91,088 | $0.96 | $87,832.54 | -2.8% | -36.4% | - | |
| Nov 25, 2025 | HOWL Werewolf Therapeutics, Inc. | Director | Sell | 125,576 | $0.92 | $115,233.61 | -3.7% | -27.5% | - | |
| Nov 20, 2025 | HOWL Werewolf Therapeutics, Inc. | Director | Sell | 102,753 | $0.92 | $94,929.51 | -2.9% | -22.9% | - | |
| Nov 17, 2025 | HOWL Werewolf Therapeutics, Inc. | Director | Sell | 134,553 | $0.96 | $128,785.31 | -3.7% | -28.4% | - | |
| Nov 12, 2025 | HOWL Werewolf Therapeutics, Inc. | Director | Sell | 137,041 | $1.13 | $154,850.07 | -3.6% | -34.2% | - | |
| Nov 6, 2025 | HOWL Werewolf Therapeutics, Inc. | Director | Sell | 155,885 | $1.22 | $189,830.23 | -4.0% | -46.5% | - | |
| Nov 3, 2025 | HOWL Werewolf Therapeutics, Inc. | Director | Sell | 189,356 | $1.33 | $251,348.62 | -4.6% | -48.2% | - |